Abiopharma

🔍 BRYANT JOHN A (Director)

Company: BALL Corp (BALL)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 2,903 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,328.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 3,369 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,959.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 3,369 shares of Deferred Compensation Company Stock Plan (Derivative)
  Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,514.68 | transaction_form_type: 4 | Footnotes: F3, F4, F4
• Acquired 327 shares of Deferred Compensation Company Stock Plan (Derivative)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,842.12 | transaction_form_type: 4 | Footnotes: F3, F5, F4, F4

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
• F2: Annual Restricted Stock Unit Award (RSU) granted to non- employee Directors under Ball Corporation's Stock and Cash Incentive Plan.
• F3: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.
• F4: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan.
• F5: Shares awarded under the Deferred Compensation Company Stock Plan for the Company match.